Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) FCF Margin: 2020-2022

Historic FCF Margin for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to -1,778.89%.

  • Therapeutics' FCF Margin fell 17015.00% to -1,778.89% in Q2 2022 from the same period last year, while for Jun 2022 it was -2,005.29%, marking a year-over-year decrease of 91332.00%. This contributed to the annual value of -4,689.98% for FY2022, which is 306971.00% down from last year.
  • Latest data reveals that Therapeutics reported FCF Margin of -1,778.89% as of Q2 2022, which was up 27.50% from -2,453.51% recorded in Q1 2022.
  • Over the past 5 years, Therapeutics' FCF Margin peaked at -503.29% during Q2 2020, and registered a low of -2,787.70% during Q4 2021.
  • For the 3-year period, Therapeutics' FCF Margin averaged around -1,439.12%, with its median value being -1,248.38% (2020).
  • Data for Therapeutics' FCF Margin shows a maximum YoY plummeted of 159,415bps (in 2021) over the last 5 years.
  • Over the past 3 years, Therapeutics' FCF Margin (Quarterly) stood at -1,193.55% in 2020, then slumped by 159,415bps to -2,787.70% in 2021, then crashed by 17,015bps to -1,778.89% in 2022.
  • Its FCF Margin stands at -1,778.89% for Q2 2022, versus -2,453.51% for Q1 2022 and -2,787.70% for Q4 2021.